NULISAâ„¢ DBS Extraction Kit recovers proteins from dried blood spot and dried plasma spot microsamples collected on leading ...
A world-first Australian trial has found that a simple fingerstick test for hepatitis B DNA is as accurate as standard lab testing, paving the way for wider access in remote and resource-limited ...
Continuous Monitoring Outperforms Fingerstick Testing in Patients With T1D, High Glycated Hemoglobin
New evidence supports the use of continuous glucose monitoring as a means to help control glycated hemoglobin levels in people with type 1 diabetes (T1D). The study, which compared continuous ...
August 27, 2010 — In the war against the transmission of bloodborne pathogens such as hepatitis B virus, the US Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration ...
Please provide your email address to receive an email when new articles are posted on . Onsite screening with a fingerstick assay at addiction treatment centers increased diagnosis and treatment of ...
A world-first Australian trial has found that a simple fingerstick test for hepatitis B DNA is as accurate as standard lab testing, paving the way for wider access in remote and resource-limited ...
In a milestone for Americans with diabetes, the Food and Drug Administration (FDA) has cleared the first-ever continuous blood sugar monitoring device that doesn’t require patients to take potentially ...
A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...
The collection of high-quality genomic DNA remains a major barrier in pediatric and neurodevelopmental research, particularly among children with autism spectrum disorder (ASD) and other neurogenetic ...
Fingerstick cardiac troponin I assay testing using thepoint-of-care i-STAT device is not accurate enough to determine the exact troponin level without the application of a corrective term. Fingerstick ...
Please provide your email address to receive an email when new articles are posted on . The FDA recently approved an expanded indication for DexCom’s G5 Mobile Continuous Glucose Monitoring System to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results